Product Information
JASMIEL 3 MG-0.02 MG TABLET is a generic product labeled by Afaxys Pharma, LLC, priced at $0.1909 per EA under NDC 50102024023. Its NADAC has been published 378 times since Jul 10, 2019.
FDA first approved this application on Feb 27, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Afaxys Pharma, LLCNDC
50102024023
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA209632FDA Approved
2/27/2018
TE Code
AB
On Market Since
2/27/2018
Price Statistics
The NADAC for JASMIEL 3 MG-0.02 MG TABLET has been published 378 times since Jul 10, 2019, and over the history we have for it it has declined 55.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1909 per EA |
|---|---|
| All-time high | $0.4860 (Aug 14, 2019) |
| All-time low | $0.1278 (Nov 20, 2024) |
| 52-week high | $0.1933 |
| 52-week low | $0.1538 |
| Median price | $0.2924 |
| Average price | $0.2899 |
| Largest weekly change | -32.1% (Nov 20, 2024) |
| Weeks tracked | 378 |
| Tracking since | Jul 10, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Afaxys Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Drospirenone and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of JASMIEL 3 MG-0.02 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for JASMIEL 3 MG-0.02 MG TABLET, manufactured by Afaxys Pharma, LLC, is $0.1909 per EA (NDC 50102024023), effective Sep 30, 2026.
How has the price of JASMIEL 3 MG-0.02 MG TABLET changed over time?
Over the history we have for it, the NADAC for JASMIEL 3 MG-0.02 MG TABLET has declined 55.4%. It has been tracked across 378 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for JASMIEL 3 MG-0.02 MG TABLET?
Since Jul 10, 2019, the NADAC for JASMIEL 3 MG-0.02 MG TABLET has ranged from a low of $0.1278 (Nov 20, 2024) to a high of $0.4860 (Aug 14, 2019), with a median of $0.2924 per EA.
Are there cheaper alternatives to JASMIEL 3 MG-0.02 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZUMANDIMINE 3 MG-0.03 MG TAB, is $0.1511 per EA — about 21% below JASMIEL 3 MG-0.02 MG TABLET.
Who manufactures JASMIEL 3 MG-0.02 MG TABLET?
JASMIEL 3 MG-0.02 MG TABLET (NDC 50102024023) is labeled by Afaxys Pharma, LLC, and CMS classifies it as a generic product.